Insider Insights
Takeda ready to file for TAK-755 enzyme replacemen...

Japan’s largest drugmaker Takeda says it aims to seek marketing authorisation for its TAK-755 enzy...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.